Nephromics (U.S. royalty obligation and worldwide diagnostics assets) is Buildings and Property in United States that focus on U.S. royalty obligation business. They cover business area such as U.S. royalty obligation, right, worldwide diagnostic asset, Nephromics, test, monitoring, risk, assessment, preeclampsia, maternal death.
-
U.S. Royalty Obligation
-
Chestnut Hill, MA
United States
Private
U.S. royalty obligationrightworldwide diagnostic assetNephromicstestmonitoringriskassessmentpreeclampsiamaternal death
* We use standard office opening hours in near Nephromics (U.S. royalty obligation and worldwide diagnostics assets)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Nephromics (U.S. Royalty Obligation And Worldwide Diagnostics Assets) is Buildings and Property business from United States that founded in - ( years old in ), Nephromics (U.S. royalty obligation and worldwide diagnostics assets) business is focusing on U.S. Royalty Obligation.
Nephromics (U.S. royalty obligation and worldwide diagnostics assets) headquarter office and corporate office address is located in Chestnut Hill, MA United States.
Nephromics (U.S. royalty obligation and worldwide diagnostics assets) was founded in United States.
In , Nephromics (U.S. royalty obligation and worldwide diagnostics assets) is currently focus on U.S. royalty obligation sector.
Above is snippet of Google Trends for "U.S. royalty obligation" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Nephromics (U.S. royalty obligation and worldwide diagnostics assets), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
